The most successful client companies were AstraZeneca, with 5 Gold awards, and UCB who won 4 Golds plus Best in Show. Other ...

Taiho is parting with $400 million upfront for Araris, a spin-off from the Paul-Scherrer-Institute in Zurich, Switzerland, ...

It’s time to shine a light on the next wave of drug discovery.

Latigo Biotherapeutics has tapped into investor interest in pain relief medicines with new, non-opioid mechanisms of action, ...

That’s why we are excited to present the 3rd Gene Therapy Potency Assay Summit, taking place in Boston from May 28-29, 2025.

The Japanese pharma company – currently in the process of rolling out new amyloid-targeting Alzheimer's therapy Leqembi ...

Robert F Kennedy Jr, former independent candidate for president and current secretary of the Department of Health and Human ...

As Global SME of Life Science and Pharma at Tive, Alex Guillen leads sales and business development within the company's rapid-growth life sciences division. Previously, Guillen served as a Board ...